G. Rumi et al., Changes of serum carotenoids in patients with esophageal, gastric, hepatocellular, pancreatic and colorectal cancer, J PHYSL-PAR, 95(1-6), 2001, pp. 239-242
The serum levels of carotenoids (vitamin A, lutein, zeaxanthin, alfa- and b
eta cryptoxanthin, alfa- and beta-carotene) were measured in healthy person
s (n=40) and in 98 patients with different malignant gastrointestinal disea
ses (44 patients with colon adenocarcinoma, 21 with gastric cancer, 15 with
hepatocellular adenocarcinoma, 10 patients with pancreas adenocarcinoma an
d eight patients with esophagus cancer). The serum levels of carotenoids we
re measured with high-pressure liquid chromatography. The sera of the patie
nts were taken at the time of the diagnosis. Results: the measurements indi
cated that (1) the serum level of vitamin A and zeaxanthin were significant
ly lower in all of these groups (except of pancreas adenocarcinoma), but th
e extent of theAdecrease was different in the patients with different types
of gastrointestinal malignancy. The serum level of vitamin A was in the he
althy subjects 2.072 +/-0.332 mmol/l and in the case of gastrointestinal ma
lignancies was 0.77 +/-0.14 mmol/l (P <0.001) The serum level of zeaxanthin
was in the healthy subjects 0.143 +/-0.057 mmol/l and at the malignancies
was 0.042 +/-0.014 mmol/l (P <0.01). (2) There were no significant differen
ces in the serum levels of other carotenoids in the checked groups. (3) The
serum level of cholesterol, total protein. albumin and haemoglobin were in
the normal range in these patients. These results indicate that the carote
noids may be responsible nutritional factors (as nutritional scavengers) in
the development of different malignant diseases. This supposed role in the
carcinogenesis does not depend fully on the vitamin A activity. (C) 2001 E
lsevier Science Ltd. All rights reserved.